A potent immunosuppressive retroviral peptide: Cytokine patterns and signaling pathways

Immunologic Research

Volumn 41, Issue 1, 2008, Pages 46-55

  Haraguchi, Soichi ^a   Good, Robert A ^a   Day Good, Noorbibi K ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Immunosuppression; Intracellular signaling pathways; Retroviral transmembrane envelope protein; Synthetic peptide; Th1 Th2 cytokines

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 5 (2 BENZOTHIAZOLYL)THIOMETHYL 4 HYDROXY 3 METHOXYBENZYLIDENECYANOACETAMIDE; 6,7 DIMETHOXY 2 PHENYLQUINOXALINE; CYCLIC AMP; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA1; PROTEIN CKS 17; PROTEIN KINASE D; RAF PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

AMINO ACID SEQUENCE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RETROVIRUS; RETROVIRUS INFECTION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CYTOKINES; ENZYME INHIBITORS; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; RETROVIRIDAE; RETROVIRIDAE PROTEINS, ONCOGENIC; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION; TH1 CELLS; TH2 CELLS; VIRAL ENVELOPE PROTEINS;

EID: 46149094601     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-007-0039-6     Document Type: Review

References (55)

1. Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985;230:453-455.
2. Cianciolo GJ, Kipnis RJ, Snyderman R. Similarity between p15E of murine and feline leukaemia viruses and p21 of HTLV. Nature 1984;311:515.
3. Oostendorp RA, Meijer CJ, Scheper RJ. Immunosuppression by retroviral-envelope-related proteins, and their role in non-retroviral human disease. Crit Rev Oncol Hematol 1993;14:189-206.
4. Haraguchi S, Good RA, Day NK. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol Today 1995;16:595-603.
5. Haraguchi S, Good RA, Cianciolo GJ, Engelman RW, Day NK. Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. J Leukoc Biol 1997;61:654-666.
6. Delwart EL, Mosialos G, Gilmore T. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat. AIDS Res Hum Retroviruses 1990;6:703-706.
7. Li X, McDermott B, Yuan B, Goff SP. Homomeric interactions between transmembrane proteins of Moloney murine leukemia virus. J Virol 1996;70:1266-1277.
8. Chan DC, Fass D, Berger JM, Kim PS. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89:263-273.
9. Weissenhorn W, Dessen A, Harrison SC, Skehel JJ, Wiley DC. Atomic structure of the ectodomain from HIV-1 gp41. Nature 1997;387:426-430.
10. Harris DT, Cianciolo GJ, Snyderman R, Argov S, Koren HS. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. J Immunol 1987;138:889-894.
11. Ogasawara M, Haraguchi S, Cianciolo GJ, Mitani M, Good RA, Day NK. Inhibition of murine cytotoxic T lymphocyte activity by a synthetic retroviral envelope peptide and abrogation of this activity by IL. J Immunol 1990;145:456-462.
12. Kleinerman ES, Lachman LB, Knowles RD, Snyderman R, Cianciolo GJ. A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. J Immunol 1987;139:2329-2337.
13. Harrell RA, Cianciolo GJ, Copeland TD, Oroszlan S, Snyderman R. Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses. J Immunol 1986;136:3517-3520.
14. Mitani M, Cianciolo GJ, Snyderman R, Yasuda M, Good RA, Day NK. Suppressive effect on polyclonal B-cell activation of a synthetic peptide homologous to a transmembrane component of oncogenic retroviruses. Proc Natl Acad Sci USA 1987;84:237-240.
15. Takahashi A, Day NK, Good RA, James-Yarish M, Haraguchi S (manuscript in preparation).
16. Nelson M, Nelson DS, Cianciolo GJ, Snyderman R. Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products. Cancer Immunol Immunother 1989;30:113-118.
17. Ogasawara M, Cianciolo GJ, Snyderman R, Mitani M, Good RA, Day NK. Human IFN-γ production is inhibited by a synthetic peptide homologous to retroviral envelope protein. J Immunol 1988;141:614-619.
18. Nelson M, Nelson D. Inhibition of interleukin-2 production by tumor cell products and by CKS-17, a synthetic retroviral envelope protein. Cancer Immunol Immunother 1990;30:331-341.
19. Haraguchi S, Liu WT, Cianciolo GJ, Good RA, Day NK. Suppression of human interferon-γ production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes. Cell Immunol 1992;141:388-397.
20. Haraguchi S, Good RA, Cianciolo GJ, Day NK. A synthetic peptide homologous to retroviral envelope protein down-regulates TNF-α and IFN-γ mRNA expression. J Leukoc Biol 1992;52:469-472.
21. Haraguchi S, Good RA, Cianciolo GJ, James-Yarish M, Day NK. Transcriptional down-regulation of tumor necrosis factor-α gene expression by a synthetic peptide homologous to retroviral envelope protein. J Immunol 1993;151:2733-2741.
22. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. Differential modulation of Th1- and Th2-related cytokine mRNA expression by a synthetic peptide homologous to a conserved domain within retroviral envelope protein. Proc Natl Acad Sci USA 1995;92:3611-3615.
23. Wan YY, Flavell RA. The roles for cytokines in the generation and maintenance of regulatory T cells. Immunol Rev 2006;212:114-130.
24. Haraguchi S, Good RA, James-Yarish M, Cianciolo GJ, Day NK. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: a possible mechanism of immunopathogenesis in retroviral infections. Proc Natl Acad Sci USA 1995;92:5568-5571.
25. Takahashi A, Day NK, Luangwedchakarn V, Good RA, Haraguchi S. A retroviral-derived immunosuppressive peptide activates mitogen-activated protein kinases. J Immunol 2001;166:6771-6775.
26. Luangwedchakarn V, Day NK, Hitchcock R, Brown PG, Lerner DL, Rucker RP, Cianciolo GJ, Good RA, Haraguchi S. A retroviral-derived peptide phosphorylates protein kinase D/protein kinase Cμ involving phospholipase C and protein kinase C. Peptides 2003;24:631-637.
27. Fan T, Day NK, Luangwedchakarn V, Chang Y, Ikehara S, Lerner DL, Haraguchi S. The phosphorylation of phospholipase C-gamma1, Raf-1, MEK, and ERK1/2 induced by a conserved retroviral peptide. Peptides 2005;26:2165-2174.
28. Baum B, Perrimon N. Spatial control of the actin cytoskeleton in drosophila epithelial cells. Nature Cell Biol 2001;3:883-890.
29. Freeman NL, Field J. Mammalian homolog of the yeast cyclase associated protein, CAP/Srv2p, regulates actin filament assembly. Cell Motil Cytoskeleton 2000;45:106-120.
30. Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today 1988;9:222-229.
31. Torgersen KM, Vang T, Abrahamsen H, Yaqub S, Taskén K. Molecular mechanisms for protein kinase A-mediated modulation of immune function. Cell Signal 2002;14:1-9.
32. Yamashita M, Kimura M, Kubo M, Shimizu C, Tada T, Perlmutter RM, Nakayama T. T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation. Proc Natl Acad Sci USA 1999;96:1024-1029.
33. Dillon S, Agrawal A, Van Dyke T, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004;172:4733-4743.
34. Agrawal A, Dillon S, Denning TL, Pulendran B. ERK-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis. J Immunol 2006;176:5788-5796.
35. Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY. Extracellualar signa-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 1999;163:6403-6412.
36. Agrawal S, Agrawal A, Doughty B, et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J Immunol 2003;171:4984-4989.
37. Pulendran B, Ahmed R. Translating innate immunity into immunological memory: implications for vaccine development. Cell 2006;124:849-863.
38. Rincón M, Enslen H, Raingeaud J, et al. Interferon-γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998;17:2817-2829.
39. Uthaisangsook S, Day NK, Hitchcock R, Lerner A, James-Yarish M, Good RA, Haraguchi S. Negative regulation of interleukin-12 production by a rapamycin-sensitive signaling pathway. Exp Biol Med 2003;228:1023-1027.
40. Fukao T, Tanabe M, Terauchi Y, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol 2002;3:875-881.
41. Haraguchi S, Luangwedchakarn V, Brown PG, Lerner DL, Good RA, Day NK (manuscript in preparation).
42. Hausser A, Storz P, Hubner S, Braendlin I, Martinez-Moya M, Link G, Johannes FJ. Protein kinase Cμ selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway. FEBS Lett 2001;492:39-44.
43. Luangwedchakarn V, Day NK, Hitchcock R, Brown PG, Good RA, Haraguchi S (manuscript in preparation).
44. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Neurobiology 2001;11:272-280.
45. Matthews SA, Rozengurt E, Cantrell D. Protein kinase D: a selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes. J Exp Med 2000;191:2075-2082.
46. Zugaza JL, Waldron RT, Sinnett-Smith J, Rozengurt E. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J Biol Chem 1997;272:23952-23960.
47. Haworth RS, Goss MW, Rozengurt E, Avkiran M. Expression and activity of protein kinase D/protein kinase Cμ in myocardium: evidence for α1-adrenergic receptor- and protein kinase C-mediated regulation. J Mol Cell Cardiol 2000;32:1013-1023.
48. Rey O, Young SH, Cantrell D, Rozengurt E. Rapid protein kinase D translocation in response to G protein-coupled receptor activation. Dependence on protein kinase C. J Biol Chem 2001;276:32616-32626.
49. Van Lint J, Ni Y, Valius M, Merlevede W, Vandendeede JR. Platelet-derived growth factor stimulates protein kinase D through the activation of phospholipase Cγ and protein kinase C. J Biol Chem 1998;273:7038-7043.
50. Bradford MD, Soltoff SP. P2X7 receptors activate protein kinse D and p42/p44 mitogen-activated protein kinase (MAPK) downstream of protein kinase C. Biochem J 2002;366:745-755.
51. Carpenter G, Ji Q. Phospholipase C-γ as a signal-transducing element. Exp Cell Res 1999;253:15-24.
52. Marra F, Pinzani M, DeFranco R, Laffi G, Gentilini P. Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett 1995;376:141-145.
53. Chaudhary LR, Hruska KA. The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 2001;81:304-311.
54. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697-715.
55. Lerner DL, Day NK, Good RA, Haraguchi S (manuscript in preparation).